These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 7281165)

  • 1. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)].
    Oudart N; Marcher K; Lacour B; Boulu RG; Guichard C
    Toxicol Eur Res; 1981 May; 3(3):149-51. PubMed ID: 7281165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
    Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
    Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats.
    Palla R; Paternoster G; Galigani P; Giovannini L; Bertelli AA; Romano MR; Alessandrì MG; Bertelli A
    Drugs Exp Clin Res; 1987; 13(12):751-6. PubMed ID: 3447879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
    Gibey R; Dupond JL; Mallet H; Guerber F; Iehl-Robert M; Flausse-Parrot F; Becker M
    Nephrologie; 1986; 7(2):51-5. PubMed ID: 3736764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 2. Preclinical determination of the urinary NAG activities and the test data of patients admitted for multiphasic screening].
    Kiyose H; Tomii M; Shimomura H; Mizuno E; Taguchi I; Inoue Y
    Rinsho Byori; 1983 Sep; Spec No 56():73-8. PubMed ID: 6663763
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
    Crovato E; Salvini R
    Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2255-60. PubMed ID: 6543318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on N-acetyl-beta-glucosaminidase (NAG) activities in the urine. II. The relation between NAG activities and various renal function tests in renal diseases].
    Uno E; Sano K
    Rinsho Byori; 1984 Apr; 32(4):419-24. PubMed ID: 6471495
    [No Abstract]   [Full Text] [Related]  

  • 9. Excretion of urinary N-acetyl-beta-D-glucosaminidase B in renal disorders & renal transplantation.
    Basu D; Joseph R; Raman PT; Johny KV
    Indian J Biochem Biophys; 1977 Mar; 14(1):77-9. PubMed ID: 336518
    [No Abstract]   [Full Text] [Related]  

  • 10. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
    Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC
    Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl-beta-D-glucosaminidase enzymuria as an indicator in monitoring the therapy of some rheumatic diseases with potentially nephrotoxic drugs.
    Wiland P; Szechiński J
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):331-6. PubMed ID: 7487376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 4. Preclinical evaluation of the urinary NAG activity and changes in renal diseases].
    Yakata M; Sugita O; Sakai T; Uchiyama K; Wada K
    Rinsho Byori; 1983 Sep; Spec No 56():90-101. PubMed ID: 6663765
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 9. Clinical study of urinary NAG activity in patients with various kidney diseases].
    Suzuki M; Asano Y
    Rinsho Byori; 1983 Sep; Spec No 56():139-46. PubMed ID: 6663755
    [No Abstract]   [Full Text] [Related]  

  • 14. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis.
    Hultberg B; Ravnskov U
    Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 8. Preclinical evaluation of the urinary NAG activities and their fluctuations in kidney diseases].
    Ishida M; Fujino N; Maeba T; Sugiyama M; Kanazawa T; Owada S; Inoue T; Ozawa S; Amakawa T
    Rinsho Byori; 1983 Sep; Spec No 56():132-8. PubMed ID: 6663754
    [No Abstract]   [Full Text] [Related]  

  • 16. [Early diagnosis of renal ischemia in arterial hypertension by means of urine N-acetyl-beta-D-glucosaminidase (author's transl)].
    García M; Méndez X; Botey A; Pons JM; Revert L
    Med Clin (Barc); 1981 Sep; 77(5):200-4. PubMed ID: 7329141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of intravenous urography using sodium and meglumine ioxitalamate (Telebrix 38) on blood creatinine and urinary excretion of N-acetyl-beta-D-glucosaminidase].
    Lacour B; Lacroix C; Jungers P; Bailly M
    Ann Biol Clin (Paris); 1984; 42(6):407-11. PubMed ID: 6532266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts].
    Ishida Y; Kawada T; Sugino N
    Rinsho Byori; 1983 Sep; Spec No 56():160-7. PubMed ID: 6363758
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary N-acetyl-beta-D-glucosaminidase in the patients with hyperthyroidism.
    Tominaga M; Fujiyama K; Hoshino T; Tanaka Y; Takeuchi T; Honda M; Mokuda O; Ikeda T; Mashiba H
    Horm Metab Res; 1989 Aug; 21(8):438-40. PubMed ID: 2793065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary N-acetyl-beta-D-glucosaminidase (NAG) as an indicator of renal disease.
    Price RG
    Curr Probl Clin Biochem; 1979; (9):150-63. PubMed ID: 446070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.